Results 231 to 240 of about 68,072 (299)

Randomized, placebo-controlled phase 3 trial evaluating safety, immunogenicity, and reactogenicity of RSVPreF3-Mat in high-risk pregnant women and their infants. [PDF]

open access: yesHum Vaccin Immunother
Bebia Z   +14 more
europepmc   +1 more source

Magnitude of Adverse Birth Outcomes and Predictors Among Newborns Delivered at Public Hospitals in Benadir Region, Somalia. [PDF]

open access: yesJ Epidemiol Glob Health
Mohamoud JH   +13 more
europepmc   +1 more source

Open fetal myeloschisis closure: pearls for uterine exposure and closure. [PDF]

open access: yesNeurosurg Focus Video
Hersh DS, Healy AJ, Crombleholme TM.
europepmc   +1 more source

Home - About - Disclaimer - Privacy